|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: MATRIX PHARMACEUTICAL INC/DE, 10-Q, 2000-11-08 |
Next: PARKER & PARSLEY 90-C CONV LP, 10-Q, 2000-11-08 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 42,191
<SECURITIES> 19,050
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 63,194
<PP&E> 19,314
<DEPRECIATION> 7,949
<TOTAL-ASSETS> 75,243
<CURRENT-LIABILITIES> 8,038
<BONDS> 11,322
0
0
<COMMON> 257,940
<OTHER-SE> (205,758)
<TOTAL-LIABILITY-AND-EQUITY> 75,243
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 6,829
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 336
<INCOME-PRETAX> (5,299)
<INCOME-TAX> 0
<INCOME-CONTINUING> (5,299)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (5,299)
<EPS-BASIC> (.21)
<EPS-DILUTED> (.21)
</TABLE>
|
|